Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ICML 2017

View all videos

Hodgkin Lymphoma

View all
2:12
Using PET to determine treatment response in Hodgkin lymphoma
Peter Johnson • 14 Jun 2017
2:27
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma
Anna Sureda • 14 Jun 2017

Non-Hodgkin Lymphoma

View all
1:01
Next steps for the use of ibrutinib and venetoclax for the treatment of lymphoma
Constantine Tam • 14 Jun 2017
3:12
An overview of the current treatment landscape of non-Hodgkin lymphoma
Franco Cavalli • 14 Jun 2017

Follicular Lymphoma

View all
2:07
Copanlisib produces promising results in relapsed/refractory follicular lymphoma
George Follows • 14 Jun 2017
1:01
Using models to predict progression in follicular lymphoma
Sarah Huet • 14 Jun 2017

Diffuse Large B-cell Lymphoma

View all
3:22
The latest data in diffuse large B-cell lymphoma from ICML 2017
Andrew Davies • 13 Jun 2017
Chemotherapy-free approaches in CLL, follicular lymphoma and DLBCL
Christian Buske • 23 Jun 2017

Mantle Cell Lymphoma

View all
Insights from the RAY trial: treating relapsed mantle cell lymphoma patients
Simon Rule • 26 Jun 2017
2:23
A novel WINDOW of opportunity for young mantle cell lymphoma patients
Michael Wang • 14 Jun 2017

Chronic Lymphocytic Leukemia

View all
Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
Susan O’Brien • 23 Jun 2017
CLL update from ICML17: Current treatment and future directions for patients
Barbara Eichhorst • 23 Jun 2017
The content of VJHemOnc is intended for healthcare professionals